SAN FRANCISCO, Calif., Oct. 7, 2025 — Verana Health announced the expansion of its MIPS Advisory Services, offering enhanced guidance for U.S. medical practices to optimize Medicare incentive payments, improve data reporting accuracy, and reduce administrative burden. The announcement coincides with the 2025 American Academy of Ophthalmology Annual Meeting.
Science Significance
The Merit-based Incentive Payment System (MIPS) integrates real-world data (RWD) and clinical insights to assess physician performance across quality, cost, and improvement activities. Verana Health’s enhanced platform leverages AI-driven data mapping and error detection algorithms to improve reporting accuracy. The technology directly supports data integrity, analytics precision, and continuous performance measurement, advancing the role of digital evidence generation in clinical operations.
Regulatory Significance
MIPS remains a key regulatory framework under the Centers for Medicare & Medicaid Services (CMS) to link reimbursement to healthcare quality. By integrating automated monitoring and compliance guidance, Verana’s service ensures practices align with federal reporting standards and avoid penalties under CMS rules. This system supports HIPAA-secure data management and enhances transparency and accountability in physician reporting.
Business Significance
Verana Health’s expanded advisory offering strengthens its market presence in regulatory data compliance and healthcare analytics. The initiative deepens its partnerships with the American Academy of Ophthalmology (IRIS Registry) and the American Urological Association (AQUA Registry), expanding its reach to thousands of specialists. By providing subscription-based compliance and coaching, Verana Health enhances recurring revenue and reinforces its leadership in health informatics and real-world data services.
Patients’ Significance
For patients, improved MIPS reporting means better quality monitoring, fewer errors in clinical documentation, and a more consistent care experience. Accurate data submission helps ensure value-based reimbursement models reward effective care, indirectly driving improved patient outcomes and reducing healthcare disparities across Medicare populations.
Policy Significance
The expansion aligns with U.S. federal policy goals promoting data-driven healthcare transparency and quality-based reimbursement. It supports CMS initiatives to simplify participation for small and medium-sized practices and underscores the growing intersection of MedTech, data governance, and national health quality policy.
Verana Health’s enhanced MIPS Advisory Services mark a critical evolution in digital healthcare compliance. By combining regulatory expertise, advanced data technology, and clinical partnerships, the company is helping U.S. physicians achieve operational excellence while improving patient outcomes and aligning with national healthcare reform goals.
Source: Verana Health Press Release



